What this clinical-stage biotech's volatile stock price tells you about the weight loss market right now
While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
What this clinical-stage biotech's volatile stock price tells you about the weight loss market right now basliginda one cikan gelisme: While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.